Free Newsletter
Top Lilly exec plays secret sales agent
Here's a little secret about Eli Lilly's U.S. president Deidre Connelly (photo): She likes to go undercover. At a recent industry conference, Connelly confided that she sometimes goes on the road as a mild-mannered pharma rep. That way, she gets the on-the-ground skinny on what her sales force is up against. (Recently, she tried to strike up a conversation with a doc who'd ignored her; he demanded to know who she was. When he saw her title on her business card, he asked, "President? President of what?")
The main thrust of Connelly's speech, though, was about what she sees as a necessary evolution in pharma sales techniques. Reps can't be all about one-way communication, but need to promote give and take so they can actually help physicians solve problems. That sort of approach requires knowledge, and lots of it, so Connelly's in favor of building up specialty sales teams from within the company.
- read this post from Pharmalot
- read the report from Medical Marketing & Media
Related Articles:
In speech, Lilly CEO calls for drug monitoring. Report
No freebies? No entry for pharma reps. Report
Groups plan new fight to limit pharma-doctor ties. Report
Thinking through pharma bans. Editorial
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment